SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-049174
Filing Date
2024-04-26
Accepted
2024-04-26 16:20:07
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS ars_2023_annual_report_-.pdf ARS 2537635
  Complete submission text file 0000950170-24-049174.txt   3494651
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39676 | Film No.: 24884088
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)